Thursday, February 9, 2012

New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …

New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …
LUND, SWEDEN–(Marketwire – 04/15/10) – – Enhanced levels of brain derived neurotrophic factor, possibly contributing to neuroprotection, were shown in laquinimod treated multiple sclerosis (MS) patients – Laquinimod significantly reduce demyelination and axonal damage as shown in animal models [...]

Cannabinoid System in Neuroprotection, Raphael Mechoulam,PhD

Professor at Hebrew University in Jerusalem, Dr. Mechoulam describes the role of Cannabinoids as anti-inflammatory for arthritis, as neuroprotectant for brain injury and as a possible treatment for PTSD. Dr. Mechoulam first isolated THC in 1964. Conference hosted by Patients Out of Time. dvds are available. medicalcannabis.com

Powered by Yahoo! Answers